Cogent Biosciences: Trio Of Approvals Beckon For Lead Drug - Still Bullish (NASDAQ:COGT)

Group 1 - The article discusses the performance of Cogent Biosciences, Inc. (COGT), highlighting that its shares were rising as the market reacted to recent data [1] - The author, Edmund Ingham, is a biotech consultant with over 5 years of experience in the biotech, healthcare, and pharma sectors, having prepared detailed reports on more than 1,000 companies [1] - The investing group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts, buy and sell ratings, product sales forecasts, and financial analyses [1]